Looking for a kick arse rate of return today? Well it’s too late to hop on the gravy train known as ARCA biopharma Inc (ABIO).
The stock is up 230% after the US Patent Office approved an ARCA patent attributed to treating heart failure.
Business Insider Emails & Alerts
Site highlights each day to your inbox.